GO Inc. Raises Funds from Fidelity International & Ryobi Group
TOKYO–(BUSINESS WIRE)–GO Inc. (Head office: Minato-ku, Tokyo; President: Hiroshi Nakajima; hereinafter, the “Company”) has raised funds... Read more.
Nidec Announces Changes to the Press Release, “Notice Regarding Commencement of Tender Offer for Takisawa Machine Tool Co., Ltd. (Securities Code: 6121)” due to Changes in Conditions to the Tender Offer to the Company
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO: 6594)(OTC US: NJDCY) (the “Tender Offeror”) decided on September 13, 2023 to acquire,... Read more.
Boehringer Ingelheim’s SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award
INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPEVIGO® (spesolimab) has been recognized as Best Orphan/Rare Diseases... Read more.
MCO Wins Best Compliance & RegTech Solution at Financial Services Dublin Awards
DUBLIN–(BUSINESS WIRE)–#asiarisk–Global conduct risk and compliance technology provider MCO (MyComplianceOffice) has been named Best Compliance... Read more.
Faraday Future Announces that the “Electrified King of Nürburgring” and World Champion Race Car Driver Romain Dumas Joins the Newly Formed “FF All Hyper Racing” Team
FF 91 2.0 dethrones the Lamborghini Urus that previously held the class record at Willow Springs Raceway. FF hosted the groundbreaking “FF Racetrack Co-Creation... Read more.
FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
– RVO is the third indication for Vabysmo, in addition to wet, or neovascular, age-related macular degeneration and diabetic macular edema – –... Read more.
Innate Pharma Announces Its Participation to Upcoming Investor Conferences
MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”)... Read more.
AM Best to Participate in Regulatory Discussion at International Insurance Society’s Global Insurance Forum
SINGAPORE–(BUSINESS WIRE)–#insurance–Rob Curtis, managing director and chief executive officer of AM Best’s Singapore operations, will participate... Read more.
InnoCare Announces First Patient Dosed in the Phase III Registrational Trial of Orelabrutinib for the Treatment of ITP in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune... Read more.
Hithium Exhibits at All-Energy Australia, Presenting the New 5 MWh Container Product
MELBOURNE, Australia–(BUSINESS WIRE)–Stationary battery manufacturer Hithium exhibited this week at the most anticipated event in the clean energy sector’s... Read more.